Status: Recruiting
Synbiotic Compound to Reduce Symptoms of Schizophrenia
The purpose of this study is to determine if taking a synbiotic supplement versus a placebo will reduce symptoms of schizophrenia when used in addition to standard antipsychotic medications.
Participants needed: 68
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Sheppard Pratt Health SystemUpdated: Apr 7, 2026Locations: 1
Eligibility criteria
Age 18-65, inclusive. [+6]
DSM-5 diagnosis of intellectual disability or comparable diagnosis determined by... [+9]